You are here:

Siponimod for secondary progressive MS: help us make the case to NICE

Published on

NICE is assessing siponimod for secondary progressive MS (SPMS) to decide whether it should be prescribed by the NHS in England and Wales.  Scotland and Northern Ireland will carry out separate appraisals.

The MS Trust will be explaining to NICE why we think siponimod should be made available on the NHS. To help us make a strong case, we want to hear your experiences of living with SPMS, your views on current NHS care for SPMS and your thoughts on siponimod.

We’d like to hear from you if you live in the UK and

  • you have secondary progressive MS
  • you have a different type of MS, but would like to add your views
  • you are a partner / friend / relative / carer of someone with SPMS
  • you are a health professional providing care for people with SPMS

Tell us what you think by completing this short questionnaire by 17 September.

Find out more

Move it for MS Nick's story

Move it for MS Nick's story

7 Oct 2021 - 00:00

Nick, was diagnosed with relapsing remitting multiple sclerosis at the start of the first lockdown. In this story we talk to him about how he coped with his diagnosis and how running helps him with his MS.

Flu season 2021

Flu season 2021

4 Oct 2021 - 00:00

This year is likely to involve a bigger flu vaccination programme in the UK, including for people with multiple sclerosis (MS), due to the circulation of Covid-19 at the same time. Here we discuss who's eligible for a flu jab on the NHS and how to get one.

Print this page